ObsEva SA

Company Description

---

Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.

Year founded

---

2012

Served area

---

Worldwide

Headquarters

---

Chemin des Aulx 12, 1228 Plan-les-Ouates – Switzerland

Shares outstanding

---

108,620,471

IPO

---

July 13, 2018

Stock exchange(s)

---

SIX Swiss Exchange